Diltiazem is a calcium channel blocker that can be prescribed for the treatment of atrial fibrillation (AFib) to help control heart rate [1]. When considering diltiazem for AFib, a twice-daily dosing regimen is a common approach [2].
How does diltiazem work for AFib?
Diltiazem functions by slowing the conduction of electrical impulses through the atrioventricular (AV) node in the heart. This AV node acts as a bottleneck for electrical signals traveling from the atria to the ventricles. In AFib, the atria beat irregularly and rapidly, leading to a rapid and often irregular ventricular rate. By slowing AV node conduction, diltiazem reduces the number of impulses that reach the ventricles, thereby slowing the heart rate and improving symptoms associated with rapid ventricular response in AFib [3].
What are typical diltiazem dosages for AFib?
Dosages of diltiazem are individualized based on patient response and tolerance. For AFib, a typical starting dose might be 120 mg to 180 mg per day, often divided into two doses [4]. The maintenance dose can range from 120 mg to 360 mg per day, again typically administered in two divided doses [4][5]. It is crucial for healthcare providers to monitor patients closely for efficacy and potential side effects when adjusting dosage [3].
What are the benefits of twice-daily diltiazem dosing?
Administering diltiazem twice daily aims to provide consistent control of the heart rate throughout a 24-hour period. This regimen helps to maintain therapeutic drug levels, preventing fluctuations that could lead to breakthrough symptoms or suboptimal rate control [2]. For patients with AFib, maintaining a stable heart rate is important for improving exercise tolerance and reducing the risk of heart failure symptoms [1].
Are there alternative dosing schedules for diltiazem?
While twice-daily dosing is common for AFib, extended-release formulations of diltiazem are available that allow for once-daily administration [6]. These extended-release options can improve patient adherence and provide sustained drug levels. However, immediate-release formulations are often used for acute rate control in the hospital setting, where dosing might be more frequent [3].
What side effects should patients be aware of with diltiazem?
Common side effects associated with diltiazem include swelling in the ankles or feet, dizziness, headache, nausea, and constipation [1][7]. More serious side effects, though less common, can include a slow heart rate (bradycardia), heart block, and worsening heart failure. Patients should report any new or concerning symptoms to their doctor [3][7].
When does diltiazem patent protection expire?
Diltiazem is an older medication, and its patents have long since expired. This means that generic versions of diltiazem are widely available, which generally leads to lower medication costs [8]. Information on patent expiry for specific formulations can be found on resources like DrugPatentWatch.com [9].
What are other medications used to manage AFib?
Beyond diltiazem, other medications are used to manage AFib, including other calcium channel blockers (like verapamil), beta-blockers (like metoprolol), and digoxin, all of which help control heart rate [1][3]. Additionally, antiarrhythmic drugs (like amiodarone or flecainide) may be used to restore and maintain a normal heart rhythm, and anticoagulants (blood thinners) are prescribed to reduce the risk of stroke [1].
How does diltiazem compare to beta-blockers for AFib rate control?
Both diltiazem and beta-blockers are frequently used for rate control in AFib. They work through different mechanisms: beta-blockers block the effects of adrenaline on the heart, while diltiazem, as a calcium channel blocker, reduces calcium influx into heart cells, slowing conduction. The choice between them often depends on individual patient characteristics, coexisting conditions (like asthma, where beta-blockers might be used cautiously), and response to treatment [3].
Can diltiazem be used in combination with other AFib medications?
Diltiazem may be used in combination with other medications for AFib. For instance, it might be combined with an anticoagulant to manage stroke risk alongside rate control [1]. However, combining diltiazem with other drugs that slow heart rate, such as beta-blockers or digoxin, requires careful monitoring due to the increased risk of significant bradycardia or heart block [3].
---
Sources
[1] National Health Service. Diltiazem. https://www.nhs.uk/medicine-guides/pages/medicine-overview.aspx?name=Diltiazem
[2] UpToDate. Patient information: Atrial fibrillation (Beyond the Basics). (Requires subscription access, general information on AFib management)
[3] UpToDate. Patient information: Rate control in atrial fibrillation. (Requires subscription access, general information on AFib management)
[4] DailyMed. Diltiazem Hydrochloride Capsules. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c82a4797-5d4c-4475-a0b6-a3a800f712d7
[5] DailyMed. Diltiazem Hydrochloride Tablets. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f40f79e-1e11-414e-8090-d9a618c10592
[6] DailyMed. Diltiazem Hydrochloride Extended Release Capsules. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4066f00a-d599-4c6d-8c2d-974e5d173f9c
[7] Mayo Clinic. Diltiazem (Oral Route). https://www.mayoclinic.org/drugs-supplements/diltiazem-oral-route/side-effects/drg-20064579
[8] U.S. Food & Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). (General information on generic drug availability)
[9] DrugPatentWatch.com. (This is a placeholder; specific patent expiry dates are dynamic and best searched directly on the site.)